Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01665794 · COMPLETED
Trial details
- NCT number
- NCT01665794
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-13
- Primary completion
- 2025-11-14
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.